Tulane Home Tulane Shield logo linking to site home page

Kidney Clinical Trials

A Phase III Randomized Study Comparing PERioperative Nivolumab vs. Observation in Patients with Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
More Information


A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the TUHC Investigator's Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma
More Information